Over-the-counter laxative polyethylene glycol 3350: an evidence-based appraisal

References

• Shah ND, Chitkara DK, Locke GR, et al. Ambulatory care for constipation in the United States, 1993–2004. Am J Gastroenterol 2008;103:1746-53
   PubMed Web of Science ®Google Scholar
• Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004;99:750-9
   PubMed Web of Science ®Google Scholar
• World Gastroenterology Organisation. World Gastroenterology Organisation practice guidelines: constipation. Available at: http://www.worldgastroenterology.org/global-guidelines.html. [Last accessed 20 November 2009]
   Google Scholar
• Lembo A, Camillieri M. Chronic constipation. N Engl J Med 2003;349:1360-8
   PubMed Web of Science ®Google Scholar
• Bracco A, Kahler K. Burden of chronic constipation must include estimate of work productivity and activity impairment in addition to traditional healthcare utilization. Am J Gastroenterol 2004;99:S233
   PubMedGoogle Scholar
• Wald A, Scarpignato C, Kamm MA, et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 2007;26:227-36
   PubMed Web of Science ®Google Scholar
• Sandler RS, Drossman DA. Bowel habits in young adults not seeking health care. Dig Dis Sci 1987;32:841-5
   PubMed Web of Science ®Google Scholar
• Ashraf W, Park F, Lof J, et al. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol 1996;91:26-32
   PubMed Web of Science ®Google Scholar
• Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91
   PubMed Web of Science ®Google Scholar
• Patel SM, Lembo AJ. Constipation. In: Feldman M, Friedman LS, Brandt LJ (eds). Sleisenger & Fordtran's Gastrointestinal and Liver Disease, 8th edn. Philadelphia, PA: Saunders, 2006
   Google Scholar
• Bharucha AE, Wald A, Enck P, et al. Functional anorectal disorders. Gastroenterol 2006;130:1510-18
   PubMed Web of Science ®Google Scholar
• Voderholzer WA, Schatke W, Mühldorfer BE, et al. Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 1997;92:95-8
   PubMed Web of Science ®Google Scholar
• Meshkinpour H, Selod S, Movahedi H, et al. Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci 1998;43:2379-83
   PubMed Web of Science ®Google Scholar
• Tuteja AK, Talley NJ, Joos SK, et al. Is constipation associated with decreased physical activity in normally active subjects? Am J Gastroenterol 2005;100:124-9
   PubMed Web of Science ®Google Scholar
• Müller-Lissner SA, Kamm MA, Scarpignato C, et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005;100:232-42
   PubMed Web of Science ®Google Scholar
• Brandt LJ, Prather CM, Quigley EMM, et al. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005;100(Suppl. 1):S5-S21
   PubMed Web of Science ®Google Scholar
• Paré P, Bridges R, Champion MC, et al. Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol 2007 (Suppl. B):3B-22B
   Google Scholar
• DiPalma AM, DiPalma JA. Polyethylene glycol laxative: a new option for constipation. Today Ther Trends 2002;20:59-67
   Google Scholar
• Pelham RW, Nix LC, Chavira RE, et al. Clinical trial: single- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects. Aliment Pharmacol Ther 2008;28:256-65
   PubMed Web of Science ®Google Scholar
• DiPalma JA, DeRidder PH, Orlando RC, et al. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000;95:446-50
   PubMed Web of Science ®Google Scholar
• Cleveland MV, Flavin DP, Ruben RA, et al. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J 2001;94:478-81
   PubMed Web of Science ®Google Scholar
• Tran LC, DiPalma JA. Lack of lasting effectiveness of PEG 3350 laxative treatment of constipation. J Clin Gastroenterol 2005;39:600-2
   PubMed Web of Science ®Google Scholar
• DiPalma JA, Cleveland MV, McGowan J, et al. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol 2007;102:1436-41
   PubMed Web of Science ®Google Scholar
• DiPalma JA, Cleveland MV, McGowan J, et al. An open-label study of chronic polyethylene glycol laxative use in chronic constipation. Aliment Pharmacol Ther 2007;25:703-8
   PubMed Web of Science ®Google Scholar
• DiPalma JA, Cleveland MV, McGowan J, et al. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications. South Med J 2007;100:1085-90
   PubMed Web of Science ®Google Scholar
• Baker SS, Liptak GS, Colletti RB, et al. for the NASPGHAN Constipation Guideline Committee. Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2006;43:e1-e13
   PubMedGoogle Scholar
• Chung S, Cheng A, Goldman RD. Polyethylene glycol 3350 without electrolytes for treatment of childhood constipation. Can Family Phys 2009;55:481-2
   PubMed Web of Science ®Google Scholar
• Nurko S, Youssef NN, Sabri M, et al. PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial. J Pediatr 2008;153:254-61
   PubMed Web of Science ®Google Scholar
• Thomson MA, Jenkins HR, Bisset WM, et al. Polyethylene glycol 3350 plus electrolytes for chronic constipation in children: a double blind, placebo controlled, crossover study. Arch Dis Child 2007;92:996-1000; erratum in: Arch Dis Child 2008;93:93
   PubMed Web of Science ®Google Scholar
• Candy D, Belsey J. Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review. Arch Dis Child 2009;94:156-60
   PubMed Web of Science ®Google Scholar
• Gremse DA, Hixon J, Crutchfield A. Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Clin Pediatr 2002;41:225-9
   PubMed Web of Science ®Google Scholar
• Voskuijl W, de Lorijn F, Verwijs W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double-blind randomised, controlled, multicentre trial. Gut 2004;53:1590-4
   PubMed Web of Science ®Google Scholar
• Loening-Baucke V, Pashankar DS. A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and Milk of Magnesia for children with constipation and fecal incontinence. Pediatrics 2006;118:528-35
   PubMed Web of Science ®Google Scholar
• Youssef NN, Peters JM, Henderson W, et al. Dose response of PEG 3350 for the treatment of childhood fecal impaction. J Pediatr 2002;141:410-14
   PubMed Web of Science ®Google Scholar
• Candy DC, Edwards D, Geraint M. Treatment of faecal impaction with polyethylene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy. J Pediatr Gastroenterol Nutr 2006;43:65-70
   PubMed Web of Science ®Google Scholar
• Pashankar DS, Loening-Baucke V, Bishop WP. Safety of polyethylene glycol 3350 for the treatment of chronic constipation in children. Arch Pediatr Adolesc Med 2003;157:661-4
   PubMed Web of Science ®Google Scholar
• Keller J, Frederking D, Layer P. The spectrum and treatment of gastrointestinal disorders during pregnancy. Nat Clin Pract Gastroenterol Hepatol 2008;5:430-43
   PubMedGoogle Scholar
• Mahadevan U, Kane S. American Gastroenterological Association Institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006;131:283-311
   PubMed Web of Science ®Google Scholar
• Tytgat GN, Heading RC, Müller-Lissner S, et al. Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Aliment Pharmacol Ther 2003;18:291-301
   PubMed Web of Science ®Google Scholar
• McCrea GS, Miaskowski C, Stotts NA, et al. Pathophysiology of constipation in the older adult. World J Gastroenterol 2008;14:2631-7
   PubMed Web of Science ®Google Scholar
• Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005;17:123-32
   PubMedGoogle Scholar
• Harari D, Gurwitz JH, Avorn J, et al. How do older persons define constipation? Implications for therapeutic management. J Gen Intern Med 1997;12:63-6
   PubMed Web of Science ®Google Scholar
• Khoshoo V, Armstead C, Landry L. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome. Aliment Pharmacol Ther 2006;23:191-6
   PubMed Web of Science ®Google Scholar
• Awad RA, Comacho S. A randomized, double-blind, placebo-controlled trial of polyethylene glycol effects on fasting and postprandial rectal sensitivity and symptoms in hypersensitive constipation-predominant irritable bowel syndrome. Colorectal Dis 2010;12(11):1131-8
   Google Scholar
• DiPalma JA, Smith JR, Cleveland MV. Overnight efficacy of polyethylene glycol laxative. Am J Gastroenterol 2002;97:1776-9
   PubMed Web of Science ®Google Scholar
• Thompson CA. Novartis suspends tegaserod sales at FDA's request. Am J Health Syst Pharm. 2007;64:1020
   PubMed Web of Science ®Google Scholar
• DiPalma JA, Cleveland MV, McGowan J, et al. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation. Am J Gastroenterol. 2007;102:1964-71
   PubMed Web of Science ®Google Scholar
• Attar A, Lémann M, Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999;44:226-30
   PubMed Web of Science ®Google Scholar
• Freedman MD, Schwartz HJ, Roby R, et al. Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial. J Clin Pharmacol 1997;37:904-7
   PubMed Web of Science ®Google Scholar
• Stoltz R, Weiss LM, Merkin DH, et al. An efficacy and consumer preference study of polyethylene glycol 3350 for the treatment of constipation in regular laxative users. Home Health Consultant 2001;8:21-6
   Google Scholar
• Hammer HF, Santa Ana CA, Schiller LR, et al. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest 1989;84:1056-62
   PubMed Web of Science ®Google Scholar
• BradyIII CE, DiPalma JA, Morawski SG, et al. Urinary excretion of polyethylene glycol electrolyte lavage solution. Gastroenterology 1986;90:1914-18
   PubMed Web of Science ®Google Scholar
• DiPalma JA. Current treatment options for chronic constipation. Rev Gastroenterol Disord 2004;4(Suppl. 3):S34-S42
   PubMedGoogle Scholar
• Eoff JC III, Lembo AJ. Optimal treatment of chronic constipation in managed care: review and roundtable discussion. J Manag Care Pharm 2008;14(Suppl. S-a):S1-S17
   PubMedGoogle Scholar
• Bleser SD. Chronic constipation: let symptom type and severity direct treatment. J Fam Pract 2006;55:587-93
   PubMed Web of Science ®Google Scholar
• Freeman HJ. ‘Melanosis’ in the small and large intestine. World J Gastroenterol 2008;21:4296-9
   Google Scholar
• McRorie JW, Daggy BP, Morel JG, et al. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 1998;12:491-7
   PubMed Web of Science ®Google Scholar
• Lacy BE, Levy LC. Lubiprostone: a novel treatment for chronic constipation. Clin Interv Aging 2008;3:357-64
   PubMed Web of Science ®Google Scholar
• Johanson JF, Morton D, Geenen J, et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol 2008;103:170-7
   PubMed Web of Science ®Google Scholar
• Johanson JF, Ueno R. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety. Aliment Pharmacol Ther 2007;25:1351-61
   PubMed Web of Science ®Google Scholar
• Amitiza [package insert]. Deerfield, IL: Takeda Pharmaceuticals America, 2008
   Google Scholar
• Dennison C, Prasad M, Lloyd A, et al. The health-related quality of life and economic burden of constipation. Pharmacoeconomics 2005;23:461-76
   PubMed Web of Science ®Google Scholar
• Martin BC, Barghout V, Cerulli A. Direct medical costs of constipation in the United States. Manag Care Interface 2006;19:43-9
   PubMedGoogle Scholar